What Medications Are Recommended for People with Emphysema?

For individuals diagnosed with emphysema—a progressive form of chronic obstructive pulmonary disease (COPD)—medication is a cornerstone of long-term management, but no drug can reverse existing lung damage. Treatment focuses on reducing symptoms, preventing exacerbations, slowing disease progression, and improving quality of life. Bronchodilators—both short-acting (e.g., albuterol, ipratropium) for immediate relief and long-acting (e.g., tiotropium, salmeterol, indacaterol, glycopyrronium) for daily maintenance—are first-line therapies. Inhaled corticosteroids (e.g., fluticasone, budesonide) are typically added for patients with frequent exacerbations or overlapping asthma features, often in combination with long-acting bronchodilators. Phosphodiesterase-4 inhibitors like roflumilast may be considered in severe COPD with chronic bronchitis and recurrent exacerbations. Antibiotics and systemic corticosteroids are reserved for acute exacerbations, not routine use. Importantly, pharmacotherapy must be individualized based on symptom burden, exacerbation history, lung function, comorbidities, and inhaler technique—and should always be guided by a pulmonologist or experienced respiratory physician. Non-pharmacologic interventions—including smoking cessation, pulmonary rehabilitation, oxygen therapy when indicated, and vaccination against influenza and pneumococcus—are equally critical components of comprehensive care.